Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
Condition: Status EpilepticusIntervention: Drug: LorazepamSponsor: PfizerNot yet recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2014 Category: Research Source Type: clinical trials
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
Condition: Status EpilepticusIntervention: Drug: LorazepamSponsor: PfizerRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2014 Category: Research Source Type: clinical trials
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
Condition: Status EpilepticusIntervention: Drug: LorazepamSponsor: PfizerNot yet recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2014 Category: Research Source Type: clinical trials
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
Condition: Status EpilepticusIntervention: Drug: LorazepamSponsor: PfizerRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2014 Category: Research Source Type: clinical trials
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
Condition: Status EpilepticusIntervention: Drug: LorazepamSponsor: PfizerNot yet recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2014 Category: Research Source Type: clinical trials
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
Condition: Status EpilepticusIntervention: Drug: LorazepamSponsor: PfizerRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2014 Category: Research Source Type: clinical trials
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
Condition: Status EpilepticusIntervention: Drug: LorazepamSponsor: PfizerRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2014 Category: Research Source Type: clinical trials
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
Condition: Status EpilepticusIntervention: Drug: LorazepamSponsor: PfizerNot yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2014 Category: Research Source Type: clinical trials
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
Condition: Status EpilepticusIntervention: Drug: LorazepamSponsor: PfizerRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2014 Category: Research Source Type: clinical trials
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
Condition: Status EpilepticusIntervention: Drug: LorazepamSponsor: PfizerRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2014 Category: Research Source Type: clinical trials
Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly
Condition: Healthy VolunteersInterventions: Drug: etifoxine; Drug: lorazepam; Drug: PlaceboSponsor: BiocodexRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2014 Category: Research Source Type: clinical trials
Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer
Condition: Advanced CancersInterventions: Drug: Lorazepam; Drug: Placebo; Drug: Haloperidol decanoate; Behavioral: QuestionnairesSponsor: M.D. Anderson Cancer CenterRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 20, 2013 Category: Research Source Type: clinical trials
